Annual Report 2024

Annual Report 2024

Consolidated Statements of Profit or Loss

Consolidated Statements of Profit or Loss

 

 

 

 

Year Ended December 31,

(in thousands of $ except for shares and EPS)

 

Note

 

2024

 

2023

 

2022

Product net sales

 

17

 

2,185,883

 

1,190,783

 

400,720

Collaboration revenue

 

15

 

4,348

 

35,533

 

10,026

Other operating income

 

16

 

61,808

 

42,278

 

34,520

Total operating income

 

 

 

2,252,039

 

1,268,594

 

445,267

 

 

 

 

 

 

 

 

 

Cost of sales

 

7

 

(227,289)

 

(117,835)

 

(29,431)

Research and development expenses

 

18

 

(983,423)

 

(859,492)

 

(663,366)

Selling, general and administrative expenses

 

19

 

(1,055,337)

 

(711,905)

 

(472,132)

Loss from investment in a joint venture

 

26

 

(7,644)

 

(4,411)

 

(677)

Total operating expenses

 

 

 

(2,273,693)

 

(1,693,643)

 

(1,165,607)

 

 

 

 

 

 

 

 

 

Operating loss

 

 

 

(21,654)

 

(425,049)

 

(720,341)

 

 

 

 

 

 

 

 

 

Financial income

 

22

 

157,509

 

107,386

 

27,665

Financial expense

 

22

 

(2,464)

 

(906)

 

(3,906)

Exchange (losses)/gains

 

22

 

(48,211)

 

14,073

 

(32,732)

 

 

 

 

 

 

 

 

 

Profit/(Loss) for the year before taxes

 

 

 

85,180

 

(304,496)

 

(729,314)

Income tax benefit

 

23

 

747,860

 

9,443

 

19,720

Profit/(Loss) for the year

 

 

 

833,040

 

(295,053)

 

(709,594)

Profit/(Loss) for the year attributable to:

 

 

 

 

 

 

 

 

Owners of the parent

 

 

 

833,040

 

(295,053)

 

(709,594)

Weighted average number of shares outstanding

 

24

 

59,855,585

 

57,169,253

 

54,381,371

Weighted average number of shares for purpose of diluted profit/(loss) per share

 

24

 

65,177,815

 

57,169,253

 

54,381,371

Basic profit/(loss) per share (in $)

 

24

 

13.92

 

(5.16)

 

(13.05)

Diluted profit/(loss) per share (in $)

 

24

 

12.78

 

(5.16)

 

(13.05)

The accompanying notes form an integral part of these consolidated financial statements.